Skip to content
Methacholine chloride
Provocholine (methacholine chloride) is a small molecule pharmaceutical. Methacholine chloride was first approved as Provocholine on 1986-10-31. It is known to target muscarinic acetylcholine receptor M4, muscarinic acetylcholine receptor M3, muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, and muscarinic acetylcholine receptor M5.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Provocholine
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Methacholine chloride
Tradename
Company
Number
Date
Products
PROVOCHOLINEMethapharmN-019193 RX1986-10-31
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
provocholine provocholine inhalation solutionNew Drug Application2022-07-12
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
V04: Diagnostic agents
V04C: Other diagnostic agents in atc
V04CX: Other diagnostic agents in atc
V04CX03: Methacholine
HCPCS
Code
Description
J7674
Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
Clinical
Clinical Trials
44 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AsthmaD001249EFO_0000270J4511551931
CoughD003371HP_0012735R05112
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E1311
Healthy volunteers/patients11
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bronchial hyperreactivityD01653544
HypersensitivityD006967EFO_0003785T78.4022
Exercise-induced asthmaD001250J45.99022
Allergic rhinitisD065631J30.911
Hypophosphatemic ricketsD063730E83.3111
DyspneaD004417HP_0002094R06.011
HivD006678O98.711
AdiposityD05015411
Respiratory hypersensitivityD01213011
Gastroesophageal refluxD005764EFO_0003948K2111
Show 1 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMETHACHOLINE CHLORIDE
INNmethacholine chloride
Description
Methacholine is a quaternary ammonium ion in which the nitrogen is substituted with three methyl groups and a 2-acetoxypropyl group. Parasympathomimetic bronchoconstrictor drug used in clinical diagnosis. It has a role as a muscarinic agonist, a bronchoconstrictor agent, an epitope, a cholinergic agonist and a vasodilator agent. It is a quaternary ammonium ion and an acetate ester.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(=O)OC(C)C[N+](C)(C)C.[Cl-]
Identifiers
PDB
CAS-ID55-92-5
RxCUI155080
ChEMBL IDCHEMBL1200764
ChEBI ID50142
PubChem CID1993
DrugBankDB06709
UNII ID0W5ETF9M2K (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
CHRM4
CHRM4
CHRM3
CHRM3
CHRM2
CHRM2
CHRM1
CHRM1
CHRM5
CHRM5
Organism
Homo sapiens
Gene name
CHRM4
Gene synonyms
NCBI Gene ID
Protein name
muscarinic acetylcholine receptor M4
Protein synonyms
acetylcholine receptor, muscarinic 4
Uniprot ID
Mouse ortholog
Chrm4 (12672)
muscarinic acetylcholine receptor M4 (Q64056)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,053 documents
View more details
Safety
Black-box Warning
Black-box warning for: Provocholine provocholine inhalation solution
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
33 adverse events reported
View more details